Roxanne Quinn

824 total citations
9 papers, 253 citations indexed

About

Roxanne Quinn is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Roxanne Quinn has authored 9 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Roxanne Quinn's work include Renal and related cancers (2 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer-related gene regulation (2 papers). Roxanne Quinn is often cited by papers focused on Renal and related cancers (2 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer-related gene regulation (2 papers). Roxanne Quinn collaborates with scholars based in United States, Australia and Canada. Roxanne Quinn's co-authors include Joyce F. Liu, Alexi A. Wright, Panagiotis A. Konstantinopoulos, Carolyn Krasner, Neil S. Horowitz, Ursula A. Matulonis, Niya Xiong, Susana M. Campos, Stephanie Morrissey and Susan Schumer and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Gynecologic Oncology.

In The Last Decade

Roxanne Quinn

9 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roxanne Quinn United States	6	129	94	70	50	44	9	253
Liz-Anne Lewsley United Kingdom	9	141 1.1×	77 0.8×	87 1.2×	15 0.3×	47 1.1×	18	254
Melanie Polin United States	6	32 0.2×	79 0.8×	24 0.3×	46 0.9×	25 0.6×	11	201
Liyuan Liu China	9	31 0.2×	88 0.9×	27 0.4×	17 0.3×	15 0.3×	21	244
Hsin‐Yuan Fang Taiwan	11	53 0.4×	186 2.0×	16 0.2×	16 0.3×	105 2.4×	30	353
Lixin Han China	7	49 0.4×	157 1.7×	12 0.2×	6 0.1×	43 1.0×	20	301
Shu Tan China	7	124 1.0×	154 1.6×	63 0.9×	6 0.1×	30 0.7×	10	404
Shouzhen Chen China	10	90 0.7×	115 1.2×	17 0.2×	10 0.2×	142 3.2×	31	335
Olesya Solheim Norway	8	57 0.4×	35 0.4×	102 1.5×	24 0.5×	24 0.5×	14	204
Zixiang Geng China	11	15 0.1×	175 1.9×	34 0.5×	26 0.5×	85 1.9×	20	294
Martine Applanat France	3	56 0.4×	101 1.1×	61 0.9×	48 1.0×	14 0.3×	4	267

Countries citing papers authored by Roxanne Quinn

Since Specialization

Citations

This map shows the geographic impact of Roxanne Quinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxanne Quinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxanne Quinn more than expected).

Fields of papers citing papers by Roxanne Quinn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roxanne Quinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxanne Quinn. The network helps show where Roxanne Quinn may publish in the future.

Co-authorship network of co-authors of Roxanne Quinn

This figure shows the co-authorship network connecting the top 25 collaborators of Roxanne Quinn. A scholar is included among the top collaborators of Roxanne Quinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roxanne Quinn. Roxanne Quinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Choi, Sharon, Roxanne Quinn, Eddy Saad, et al.. (2024). Efficacy of post-lenvatinib treatments in patients (pts) with advanced renal cell carcinoma (aRCC).. Journal of Clinical Oncology. 42(16_suppl). 4538–4538. 2 indexed citations

Liu, Joyce F., Niya Xiong, Susana M. Campos, et al.. (2021). Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma. Journal of Clinical Oncology. 39(14). 1531–1539. 115 indexed citations

Osypiuk, Kamila, Jennifer A. Ligibel, Anita Giobbie‐Hurder, et al.. (2020). Qigong Mind-Body Exercise as a Biopsychosocial Therapy for Persistent Post-Surgical Pain in Breast Cancer: A Pilot Study. Integrative Cancer Therapies. 19. 1871112198–1871112198. 40 indexed citations

Lee, Elizabeth K., Niya Xiong, Su–Chun Cheng, et al.. (2020). Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trial. Gynecologic Oncology. 159(1). 72–78. 64 indexed citations

Tayob, Nabihah, Susana M. Campos, Alexi A. Wright, et al.. (2020). A phase II trial of the Wee1 inhibitor adavosertib (AZD1775) in recurrent uterine serous carcinoma. Gynecologic Oncology. 159. 5–5. 3 indexed citations

Liu, Joyce F., Niya Xiong, Susana M. Campos, et al.. (2020). A phase II trial of the Wee1 inhibitor adavosertib (AZD1775) in recurrent uterine serous carcinoma.. Journal of Clinical Oncology. 38(15_suppl). 6009–6009. 8 indexed citations

Konstantinopoulos, Panagiotis A., Joyce F. Liu, Weixiu Luo, et al.. (2019). Phase 2, two-group, two-stage study of avelumab in patients (pts) with microsatellite stable (MSS), microsatellite instable (MSI), and polymerase epsilon (POLE) mutated recurrent/persistent endometrial cancer (EC).. Journal of Clinical Oncology. 37(15_suppl). 5502–5502. 7 indexed citations

Hendrickson, Andrea E. Wahner, Richard T. Penson, Austin Doyle, et al.. (2019). Randomized phase II (RP2) study of ATR inhibitor M6620 in combination with gemcitabine versus gemcitabine alone in platinum-resistant high grade serous ovarian cancer (HGSOC). Annals of Oncology. 30. v897–v897. 5 indexed citations

Verschraegen, Claire F., et al.. (2008). Phase I/II study of docetaxel (D), gemcitabine (G), and bevacizumab (B) in patients (pts) with advanced or recurrent soft tissue sarcoma (STS). Journal of Clinical Oncology. 26(15_suppl). 10534–10534. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact